BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Diagnosis
31 results:

  • 1. A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma.
    Liang Y; Xu F; Mou Q; Wang Z; Xiao C; Zhou T; Zhang N; Yang J; Wu H
    BMC Med Imaging; 2024 Jan; 24(1):27. PubMed ID: 38273242
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
    Zhang PR; Ma XL; Guo L; Lu RQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
    [No Abstract]    [Full Text] [Related]  

  • 3. [Evaluation of clinical safety and diagnostic efficacy of domestic liver-specific magnetic resonance contrast agent (gadoxetate disodium)].
    Yang T; Ye Z; Yao S; Li Y; Song B
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):161-167. PubMed ID: 37137831
    [No Abstract]    [Full Text] [Related]  

  • 4. Association of oral lichen planus with hepatic disorders and hepatocellular carcinoma: systematic review and meta-analysis.
    González-Moles MÁ; de Porras-Carrique T; Ramos-García P
    Med Oral Patol Oral Cir Bucal; 2023 May; 28(3):e229-e237. PubMed ID: 36806023
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
    Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
    Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
    Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty liver Disease-Related Hepatocellular cancer (NAFLD-HCC).
    Chu J; Cholankeril G; Yu X; Rana A; Natarajan Y; El-Serag HB; Kramer J; Kanwal F
    Dig Dis Sci; 2023 Mar; 68(3):1060-1070. PubMed ID: 35759159
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of the Frequency and Quantity of Alcohol Consumption With Gastrointestinal cancer.
    Yoo JE; Shin DW; Han K; Kim D; Jeong SM; Koo HY; Yu SJ; Park J; Choi KS
    JAMA Netw Open; 2021 Aug; 4(8):e2120382. PubMed ID: 34406403
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Generation of a nanobody-alkaline phosphatase fusion and its application in an enzyme cascade-amplified immunoassay for colorimetric detection of alpha fetoprotein in human serum.
    Su B; Xu H; Xie G; Chen Q; Sun Z; Cao H; Liu X
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Dec; 262():120088. PubMed ID: 34167066
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Vicentin I; Mosconi C; Garanzini E; Sposito C; Serenari M; Buscemi V; Verna M; Spreafico C; Golfieri R; Mazzaferro V; De Carlis L; Cescon M; Ercolani G; Vanzulli A; Cucchetti A
    Eur Radiol; 2021 Dec; 31(12):8903-8912. PubMed ID: 34117911
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced liver Fibrosis.
    Kozumi K; Kodama T; Murai H; Sakane S; Govaere O; Cockell S; Motooka D; Kakita N; Yamada Y; Kondo Y; Tahata Y; Yamada R; Hikita H; Sakamori R; Kamada Y; Daly AK; Anstee QM; Tatsumi T; Morii E; Takehara T
    Hepatology; 2021 Nov; 74(5):2452-2466. PubMed ID: 34105780
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
    Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
    Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
    Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
    Song T; Wang L; Xin R; Zhang L; Tian Y
    J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Spectrum of malignancies among the population of adults living with HIV infection in China: A nationwide follow-up study, 2008-2011.
    Zhu W; Mao Y; Tang H; McGoogan JM; Zhang ZF; Detels R; He N; Wu Z
    PLoS One; 2019; 14(7):e0219766. PubMed ID: 31344059
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
    Schreckenbach T; Hübert H; Koch C; Bojunga J; Schnitzbauer AA; Bechstein WO; Holzer K
    Eur J Surg Oncol; 2019 May; 45(5):808-815. PubMed ID: 30611565
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: The impact of pre-existing diabetes mellitus.
    Li Z; Gao Z; Xiang J; Zhou J; Yan S; Hu Z
    Liver Int; 2019 Feb; 39(2):361-370. PubMed ID: 30276959
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
    Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies.
    Xiu Y; Sun B; Jiang Y; Wang A; Liu L; Liu Y; Sun S; Huangfu M
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):384-389. PubMed ID: 29924656
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation.
    Kim T; Song C; Han JH; Kim IA; Kim YJ; Kim SH; Kim JH; Kim CY
    Cancer Res Treat; 2018 Jan; 50(1):164-174. PubMed ID: 28324921
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.